Bioactive Fraction of Streptomyces thinghirensis MSA1 Effectively Inhibits Biofilm Forming Clinically Significant AMR...

The escalating threat of antibiotic-resistant microorganisms necessitate the discovery of novel antibacterial agents. This study explores the potential of marine-associated actinomycetes, focusing on Streptomyces thinghirensis MSA1, isolated from the marine sponge Callyspongia diffusa in Palk Bay, India, for its notable antibacterial properties. To optimize the production of bioactive compounds of S. thinghirensis MSA1, we established optimal growth conditions (30 °C, pH 7, 2% salinity, 9-day incubation) and utilized ISP4 medium for enhanced secondary metabolite production. The extracted compound, MSA1, was analyzed through FTIR and GCMS, identifying 20 biologically active components. MSA1 demonstrated potent antibacterial activity against significant pathogens, including Escherichia coli, Klebsiella pneumoniae, Salmonella typhi, Pseudomonas aeruginosa, and MRSA, alongside remarkable antioxidant and anti-biofilm properties. These findings highlight the potential of MSA1 as a promising candidate for developing treatments against antibiotic-resistant infections. This study acknowledges the preliminary nature of the findings and the necessity for further in vivo and clinical trials to fully ascertain the therapeutic potential of MSA1. This research opens avenues for novel antibacterial agents in the fight against antibiotic resistance, underscoring the value of marine biodiversity in medical science.